Lexaria Bioscience Corp (LEXX)
3.12
+0.24
(+8.33%)
USD |
NASDAQ |
May 24, 16:00
3.10
-0.02
(-0.64%)
After-Hours: 20:00
Lexaria Bioscience Gross Profit (TTM): 0.3684M for Feb. 29, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
February 29, 2024 | 0.3684M |
November 30, 2023 | 0.2405M |
August 31, 2023 | 0.176M |
May 31, 2023 | 0.2493M |
February 28, 2023 | 0.25M |
November 30, 2022 | 0.2572M |
August 31, 2022 | 0.1836M |
May 31, 2022 | 0.1244M |
February 28, 2022 | 0.1874M |
November 30, 2021 | 0.3245M |
August 31, 2021 | 0.5474M |
May 31, 2021 | 0.5876M |
February 28, 2021 | 0.4596M |
November 30, 2020 | 0.2776M |
August 31, 2020 | 0.0489M |
May 31, 2020 | 0.1082M |
February 29, 2020 | 0.1489M |
November 30, 2019 | 0.1821M |
August 31, 2019 | 0.1997M |
May 31, 2019 | 0.183M |
February 28, 2019 | 0.264M |
November 30, 2018 | 0.4096M |
August 31, 2018 | 0.4081M |
May 31, 2018 | 0.3224M |
February 28, 2018 | 0.2046M |
Date | Value |
---|---|
November 30, 2017 | 0.0441M |
August 31, 2017 | 0.0339M |
May 31, 2017 | 0.032M |
February 28, 2017 | 0.0088M |
November 30, 2016 | 0.007M |
August 31, 2016 | -0.0049M |
May 31, 2016 | -0.0243M |
February 29, 2016 | -0.0237M |
November 30, 2015 | -0.0188M |
August 31, 2015 | |
May 31, 2015 | |
February 28, 2015 | |
November 30, 2014 | |
July 31, 2014 | -0.1481M |
April 30, 2014 | -0.1257M |
January 31, 2014 | -0.0949M |
October 31, 2013 | 0.00 |
July 31, 2013 | 0.4962M |
April 30, 2013 | 0.6852M |
January 31, 2013 | 0.5986M |
October 31, 2012 | 0.5745M |
July 31, 2012 | 0.5357M |
April 30, 2012 | 0.445M |
January 31, 2012 | 0.5191M |
October 31, 2011 | 0.4659M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
0.0489M
Minimum
Aug 2020
0.5876M
Maximum
May 2021
0.2552M
Average
0.2201M
Median
Gross Profit (TTM) Benchmarks
Sunshine Biopharma Inc | 8.865M |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 161.36M |
Edesa Biotech Inc | -- |
Xenon Pharmaceuticals Inc | -- |